IPCA asks USFDA to clarify on Hydroxychloroquine risk

Hydroxychloroquine, besides being administered as an anti-malarial drug, is also used as a chronic therapy by patients suffering from auto immune diseases such as RA and Lupus. In the recent months the drug has been used in several countries including India and US in the treatment of critically ill Covid-19 patients.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news